Trump’s FDA Cuts Are Putting Drug Development at Risk
-
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon
Musk’s cost-cutting measures could slow drug research and delay FDA
approvals.
9 hours ago
2 comments:
Give it a rest already.
Amen.
Post a Comment